Search results
Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy
Pharmaceutical Technology· 6 days agoSuch broad use is expected to increase Dupixent sales, with the therapy expected to generate $19.8bn...
FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market
Clinical Trials Arena· 6 days agoThe FDA has approved Verona Pharma’s first-in-class dual phosphodiesterase 3/4 inhibitor, Ohtuvayre...
US FDA approves Verona Pharma's inhaled COPD therapy - ET HealthWorld | Pharma
The Economic Times· 7 days agoLondon: The U.S. Food and Drug Administration has granted approval to a treatment from Verona Pharma...
FDA approves new COPD drug developed by firm in Raleigh. First new treatment in a decade
Durham Herald-Sun· 6 days agoHan previously consulted for Verona Pharma but was not involved in the clinical trial. First new...
EURO 2024 – Switzerland vs Italy: Ticket prices, kick-off time and where to watch on TV
Football Italia· 6 days agoItaly and Switzerland meet in the EURO 2024 Round of 16 in Berlin on June 29 at 18:00 CET. Here’s...